Heart attack patients try new drug plan to cut bleeding risk
NCT ID NCT04755387
Summary
This study is testing a new, two-step plan for blood-thinning medications after a heart attack. It aims to lower the risk of serious bleeding by reducing the dose of one drug and stopping another earlier than usual, while still protecting against future heart problems. The trial will compare this new plan to the standard medication approach in over 2,300 people who have had a heart attack.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DongA University Hospital
RECRUITINGBusan, 602-715, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.